
Amylin Pharmaceuticals has rebuffed a $3.5 billion unsolicited takeover bid from Bristol-Myers Squibb, according to reports. Shares in Amylin rose …

Lilly has unveiled a range of collaborations with academic researchers which it says will help it discover and develop more …

There was more good news for Ireland’s pharmaceutical sector this week with the announcement by Eli Lilly that it will …
An independent study by academics has concluded that GLP-1 agonist drugs help patients to lose weight – with the effect …

Lilly is forecasting a drop in revenue and profits for 2012, as it prepares for life without its blockbuster antipsychotic …
Eli Lilly has filed a planning application to build a new 23,000 sq. m. biologics facility at its manufacturing site …
Lilly has elected Katherine Baicker as a new member of its board of directors, effective immediately. Baicker, 40, is Professor …
Thomas Thorp has been promoted to senior director of corporate affairs at Lilly UK. Thorp will now lead all of …

Amylin will pay up to $1.6 billion to end its diabetes pact with Lilly after a difficult year for the …
The FDA has approved the use of Lilly and Amylin’s diabetes treatment Byetta as an add-on therapy to insulin glargine.The …
Lilly has launched a new open innovation platform designed to help build its pipeline and to identify new treatments for …

One year after launching its corporate blog Lilly is ramping up its use of social media. Last week the company …
Eli Lilly is reportedly eyeing up a partnership with Turkish drugmaker Mustafa Nevzat Ilac Sanayi (MN Pharmaceuticals) in order to …

Lilly has released details of its payments to doctors and healthcare organisations in the US. The company paid $48.1 million …